McCloskey D E, Pegg A E
Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA.
J Biol Chem. 2000 Sep 15;275(37):28708-14. doi: 10.1074/jbc.M004120200.
To develop a model system to investigate mechanisms of antiproliferative action of bis(ethyl)polyamine analogues, intermittent analogue treatments followed by recovery periods in drug-free medium were used to select an N(1), N(12)-bis(ethyl)spermine-resistant derivative of the Chinese hamster ovary cell line C55.7. The resulting C55.7Res line was at least 10-fold resistant to N(1),N(12)-bis(ethyl)spermine and N(1), N(11)-bis(ethyl)norspermine. The stability of the resistance in the absence of selection pressure was >/=9 months, indicating that a heritable genotypic change was responsible for the resistance phenotype. Polyamine transport alterations and multi-drug resistance were eliminated as causes of the resistance. Spermidine/spermine N(1)-acetyltransferase (SSAT) activity and regulation were altered in C55.7Res cells as basal activity was decreased, and no activity induction resulted from exposure to analogue concentrations, which caused 300-fold enzyme induction in parental cells. SSAT mRNA levels in the absence and presence of analogue were unchanged, but no SSAT protein was detected in C55.7Res cells. A point mutation, which results in the change leucine156 (a fully conserved residue) to phenylalanine, was identified in the C55.7Res SSAT cDNA. Expression of wtSSAT activity in C55.7Res cells restored sensitivity to bis(ethyl)polyamines. These results provided definitive evidence that SSAT activity is a critical target of the cytotoxic action of these analogues.
为了开发一个模型系统来研究双(乙基)多胺类似物的抗增殖作用机制,采用间歇性类似物处理,随后在无药物培养基中恢复的方法,从中国仓鼠卵巢细胞系C55.7中筛选出对N(1), N(12)-双(乙基)精胺耐药的衍生物。得到的C55.7Res细胞系对N(1),N(12)-双(乙基)精胺和N(1), N(11)-双(乙基)去甲精胺的耐药性至少高10倍。在没有选择压力的情况下,耐药性的稳定性大于或等于9个月,这表明耐药表型是由可遗传的基因型变化引起的。多胺转运改变和多药耐药被排除为耐药原因。C55.7Res细胞中的亚精胺/精胺N(1)-乙酰转移酶(SSAT)活性和调节发生了改变,基础活性降低,暴露于类似物浓度下不会诱导活性,而在亲代细胞中这会导致300倍的酶诱导。在有无类似物存在的情况下,SSAT mRNA水平没有变化,但在C55.7Res细胞中未检测到SSAT蛋白。在C55.7Res SSAT cDNA中鉴定出一个点突变,该突变导致亮氨酸156(一个完全保守的残基)变为苯丙氨酸。在C55.7Res细胞中表达野生型SSAT活性可恢复对双(乙基)多胺的敏感性。这些结果提供了确凿的证据,表明SSAT活性是这些类似物细胞毒性作用的关键靶点。